SCHEMBL7758049

SCHEMBL7758049

CC(C)CC/N=C(\NC#N)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 4/20 0.44
TBXA2R P21731 1/20 0.41
TBXAS1 P24557 1/20 0.41
NAMPT P43490 5/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.38
ABCC9 O60706 5/20 0.37
KCNJ11 Q14654 5/20 0.37
CYP3A4 P08684 2/20 0.36
LMNA P02545 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GLA P06280 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4260989 1.00 QPCT (0.44) QPCTTBXA2RTBXAS1NAMPTALDH1A1
SCHEMBL4260986 1.00 QPCT (0.44) QPCTTBXA2RTBXAS1NAMPTALDH1A1
SCHEMBL7758575 0.90 QPCT (0.40) QPCTTBXA2RTBXAS1NAMPTKCNJ11
SCHEMBL7758570 0.90 QPCT (0.40) QPCTTBXA2RTBXAS1NAMPTKCNJ11
SCHEMBL8134099 0.86 QPCT (0.47) QPCTNAMPTALDH1A1MAPTABCC9
SCHEMBL8134103 0.86 QPCT (0.47) QPCTNAMPTALDH1A1MAPTABCC9
SCHEMBL7753776 0.81 TBXA2R (0.42) QPCTTBXA2RTBXAS1NAMPTABCC9
SCHEMBL7753772 0.81 TBXA2R (0.42) QPCTTBXA2RTBXAS1NAMPTABCC9
SCHEMBL8143180 0.80 KCNJ11 (0.56) ALDH1A1MAPTABCC9KCNJ11CYP3A4
SCHEMBL8143177 0.80 KCNJ11 (0.56) ALDH1A1MAPTABCC9KCNJ11CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147098-A USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM, PULMONARY SYSTEM, GASTROINTESTINAL SYSTEM AND ENDOCRINOLOGIC SYSTEM NOVO NORDISK A/S (DK) 2000-11-14 US claimed
EP-1077933-A1 SUBSTITUTED GUANIDINES AND DIAMINONITROETHENES, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 2001-02-28 EP disclosed
US-6147098-A USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM, PULMONARY SYSTEM, GASTROINTESTINAL SYSTEM AND ENDOCRINOLOGIC SYSTEM NOVO NORDISK A/S (DK) 2000-11-14 US disclosed
WO-1999058497-A1 SUBSTITUTED GUANIDINES AND DIAMINONITROETHENES, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1999-11-18 WO disclosed